Dr. Soley Bayraktar, MD

Dr. Bayraktar practices at University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System.

Dr. Bayraktar's NPI, 1437331493, was assigned on December 3, 2007. Dr. Bayraktar holds Florida license ME140039.

Dr. Bayraktar's primary practice is University Hospitals Cleveland Medical Center, at 11100 Euclid Avenue, Cleveland, OH 44106 in Cuyahoga County. The practice phone is (216) 844-1000.

Dr. Bayraktar's primary practice is University Hospitals Cleveland Medical Center in Cleveland, Ohio, part of University Hospitals Health System. Dr. Bayraktar is also affiliated with University Hospitals TriPoint Medical Center. The medical group on file is University Hospitals Medical Practices. Dmand AI also links Dr. Bayraktar to 3 more hospitals, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bayraktar practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Bayraktar's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. Bayraktar's licenses on file in 3 states: Florida, Oklahoma and Wisconsin.

CMS data shows 636 Medicare services from Dr. Bayraktar across 6 procedure codes in 2024, for 321 Medicare patients. Medicare paid $65,130 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 321 Medicare patients who saw Dr. Bayraktar in 2024. The largest group is 75 to 84, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bayraktar's median patient age at 73, with 59% women.

In 2024, Dr. Bayraktar wrote 1,426 Medicare Part D claims for 388 patients. 83% of them were for generic drugs. CMS names the drug for 1,139 of them, across 34 drugs with 11 or more claims each, at $2,013,263 in total drug cost. In 2023, CMS named 2,427 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Bayraktar for performance year 2024, reported through an alternative payment model (APM). Dr. Bayraktar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bayraktar as offering telehealth.

CMS Open Payments shows 49 general payments to Dr. Bayraktar from 23 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 91% of the total. Sanofi and Genzyme US Companies paid the most, $170.